Kristin Boehm
Plastic and Reconstructive Surgery · Atlanta, GANPI 1093713208
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $13,501 of the $18,487 with a category attached, or 73.0%. AbbVie accounts for 69.3% of it on its own, with 18 other manufacturers making up the rest. Reporting peaked in 2023 at $4,156 and has fallen 65.7% since, to $1,427 in 2025.
Across 337 payments — averaging $54.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$13K
- Musculoskeletal Transplant Foundation Inc.$2K
- Mentor Worldwide LLC$943
- Galderma Laboratories, L.p.$721
- Bard Peripheral Vascular, Inc.$658
- Orthoxel Designated Activity Company$500
- plus $875 from 13 others
What the payments were for
- Consulting fees$5003%
- Speaking & faculty fees$9085%
- Travel & lodging$3,47719%
- Food & beverage$13,50173%
- Education$1011%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 261 | $12,819 |
| Musculoskeletal Transplant Foundation Inc. | 8 | $1,970 |
| Mentor Worldwide LLC | 12 | $943 |
| Galderma Laboratories, L.p. | 23 | $721 |
| Bard Peripheral Vascular, Inc. | 8 | $658 |
| Orthoxel Designated Activity Company | 1 | $500 |
| Merz North America, Inc. | 5 | $283 |
| Davol Inc. | 3 | $164 |
| Tepha Inc | 1 | $94 |
| Integra Lifesciences Corporation | 4 | $89 |
| Endo Pharmaceuticals Inc. | 2 | $86 |
| Otsuka America Pharmaceutical, Inc. | 2 | $42 |
| Merck | 1 | $22 |
| Trevena, Inc. | 1 | $20 |
| Halozyme Inc | 1 | $19 |
| Medtronic | 1 | $17 |
| Viiv Healthcare Company | 1 | $17 |
| Novo Nordisk | 1 | $15 |
| Aroa Biosurgery Incorporated | 1 | $8 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$18,487 in reported general payments places this provider in the 80th percentile of 83 plastic and reconstructive surgery providers in Georgia.
See all plastic and reconstructive surgery providers in Georgia →
Other plastic and reconstructive surgery in Atlanta
- Carmen KavaliAtlanta$233K
- James NamnoumAtlanta$97K
- Michael MirzabeigiAtlanta$71K
- Katherine SantosaAtlanta$65K
- Alexis TashimaAtlanta$22K
- Grace MaAtlanta$17K
- Lindsey WebbAtlanta$10K
- Mark CrispinAtlanta$6K
- Joseph WilliamsAtlanta$5K
- Paul GhareebAtlanta$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.